Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
11919 | 945 | 34.4 | 71% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
11 | 3 | ATRIAL FIBRILLATION//CARDIAC & CARDIOVASCULAR SYSTEM//CATHETER ABLATION | 130936 |
1064 | 2 | LONG QT SYNDROME//BRUGADA SYNDROME//QT INTERVAL | 10012 |
11919 | 1 | SERTINDOLE//TORSADES DE POINTES//TORSADE DE POINTES | 945 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SERTINDOLE | authKW | 720270 | 6% | 42% | 53 |
2 | TORSADES DE POINTES | authKW | 380100 | 8% | 15% | 78 |
3 | TORSADE DE POINTES | authKW | 373156 | 8% | 16% | 74 |
4 | QT PROLONGATION | authKW | 295110 | 6% | 15% | 59 |
5 | QTC PROLONGATION | authKW | 188694 | 3% | 23% | 25 |
6 | PSYCHOPHARMACOL VENTURE | address | 161555 | 1% | 100% | 5 |
7 | QT INTERVAL | authKW | 140645 | 8% | 6% | 71 |
8 | QT INTERVAL PROLONGATION | authKW | 72786 | 1% | 17% | 13 |
9 | CLIN TOXICOL PHARMACOL | address | 66196 | 2% | 12% | 17 |
10 | DRUG INDUCED QTC INTERVAL PROLONGATION | authKW | 64622 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 4355 | 40% | 0% | 380 |
2 | Psychiatry | 3685 | 23% | 0% | 218 |
3 | Cardiac & Cardiovascular System | 1592 | 17% | 0% | 161 |
4 | Medicine, General & Internal | 647 | 13% | 0% | 127 |
5 | Emergency Medicine | 350 | 3% | 0% | 26 |
6 | Toxicology | 297 | 6% | 0% | 57 |
7 | Critical Care Medicine | 119 | 3% | 0% | 24 |
8 | Clinical Neurology | 72 | 5% | 0% | 51 |
9 | Medicine, Legal | 59 | 1% | 0% | 9 |
10 | Psychology, Clinical | 45 | 2% | 0% | 19 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PSYCHOPHARMACOL VENTURE | 161555 | 1% | 100% | 5 |
2 | CLIN TOXICOL PHARMACOL | 66196 | 2% | 12% | 17 |
3 | EA NEUROCARDIOL PHYSIOPATHOL TROUBLES RYTHME CARD | 64622 | 0% | 100% | 2 |
4 | KENT DEV | 64622 | 0% | 100% | 2 |
5 | ABT PEDIATR KARDIOL | 32311 | 0% | 100% | 1 |
6 | ABT VERSORGUNGS FOR | 32311 | 0% | 100% | 1 |
7 | ANESTHESIOL CRIT CARE MEDARMSTRONG P | 32311 | 0% | 100% | 1 |
8 | ATTIKON GEN HOSPCLIN MOL PSYCHOGENET UNIT | 32311 | 0% | 100% | 1 |
9 | BLACKROCK | 32311 | 0% | 100% | 1 |
10 | CARDIOLST ANTONIUS HOSP NIEUWEGEIN | 32311 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 6738 | 2% | 1% | 22 |
2 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 5236 | 2% | 1% | 21 |
3 | PSYCHOPHARMAKOTHERAPIE | 4145 | 1% | 2% | 8 |
4 | INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE | 3209 | 1% | 1% | 9 |
5 | PHARMACOTHERAPY | 3109 | 2% | 0% | 21 |
6 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2866 | 3% | 0% | 27 |
7 | DRUG SAFETY | 2596 | 1% | 1% | 13 |
8 | INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 2515 | 1% | 1% | 12 |
9 | JOURNAL OF CLINICAL PSYCHIATRY | 1617 | 2% | 0% | 19 |
10 | EXPERT OPINION ON DRUG SAFETY | 1516 | 1% | 1% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SERTINDOLE | 720270 | 6% | 42% | 53 | Search SERTINDOLE | Search SERTINDOLE |
2 | TORSADES DE POINTES | 380100 | 8% | 15% | 78 | Search TORSADES+DE+POINTES | Search TORSADES+DE+POINTES |
3 | TORSADE DE POINTES | 373156 | 8% | 16% | 74 | Search TORSADE+DE+POINTES | Search TORSADE+DE+POINTES |
4 | QT PROLONGATION | 295110 | 6% | 15% | 59 | Search QT+PROLONGATION | Search QT+PROLONGATION |
5 | QTC PROLONGATION | 188694 | 3% | 23% | 25 | Search QTC+PROLONGATION | Search QTC+PROLONGATION |
6 | QT INTERVAL | 140645 | 8% | 6% | 71 | Search QT+INTERVAL | Search QT+INTERVAL |
7 | QT INTERVAL PROLONGATION | 72786 | 1% | 17% | 13 | Search QT+INTERVAL+PROLONGATION | Search QT+INTERVAL+PROLONGATION |
8 | DRUG INDUCED QTC INTERVAL PROLONGATION | 64622 | 0% | 100% | 2 | Search DRUG+INDUCED+QTC+INTERVAL+PROLONGATION | Search DRUG+INDUCED+QTC+INTERVAL+PROLONGATION |
9 | HERG BLOCKADE | 64622 | 0% | 100% | 2 | Search HERG+BLOCKADE | Search HERG+BLOCKADE |
10 | PROLONGATION OF QT INTERVAL | 64622 | 0% | 100% | 2 | Search PROLONGATION+OF+QT+INTERVAL | Search PROLONGATION+OF+QT+INTERVAL |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HASNAIN, M , VIEWEG, WVR , (2014) QTC INTERVAL PROLONGATION AND TORSADE DE POINTES ASSOCIATED WITH SECOND-GENERATION ANTIPSYCHOTICS AND ANTIDEPRESSANTS: A COMPREHENSIVE REVIEW.CNS DRUGS. VOL. 28. ISSUE 10. P. 887 -920 | 68 | 39% | 19 |
2 | ZELTSER, D , JUSTO, D , HALKIN, A , PROKHOROV, F , HELLER, K , VISKIN, S , (2003) TORSADE DE POINTES DUE TO NONCARDIAC DRUGS - MOST PATIENTS HAVE EASILY IDENTIFIABLE RISK FACTORS.MEDICINE. VOL. 82. ISSUE 4. P. 282-290 | 62 | 53% | 108 |
3 | GUO, DH , CAI, Y , CHAI, D , LIANG, BB , BAI, N , WANG, R , (2010) THE CARDIOTOXICITY OF MACROLIDES: A SYSTEMATIC REVIEW.PHARMAZIE. VOL. 65. ISSUE 9. P. 631-640 | 34 | 77% | 12 |
4 | ZOCCALI, RA , BRUNO, A , MUSCATELLO, MRA , (2015) EFFICACY AND SAFETY OF SERTINDOLE IN SCHIZOPHRENIA A CLINICAL REVIEW.JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. VOL. 35. ISSUE 3. P. 286 -295 | 41 | 53% | 0 |
5 | TITIER, K , GIRODET, PO , VERDOUX, H , MOLIMARD, M , BEGAUD, B , HAVERKAMP, W , LADER, M , MOORE, N , (2005) ATYPICAL ANTIPSYCHOTICS - FROM POTASSIUM CHANNELS TO TORSADE DE POINTES AND SUDDEN DEATH.DRUG SAFETY. VOL. 28. ISSUE 1. P. 35-51 | 44 | 57% | 57 |
6 | JUSTO, D , ZELTSER, D , (2006) TORSADES DE POINTES INDUCED BY ANTIBIOTICS.EUROPEAN JOURNAL OF INTERNAL MEDICINE. VOL. 17. ISSUE 4. P. 254-259 | 38 | 66% | 13 |
7 | BEACH, SR , CELANO, CM , NOSEWORTHY, PA , JANUZZI, JL , HUFFMAN, JC , (2013) QTC PROLONGATION, TORSADES DE POINTES, AND PSYCHOTROPIC MEDICATIONS.PSYCHOSOMATICS. VOL. 54. ISSUE 1. P. 1 -13 | 33 | 45% | 61 |
8 | OWENS, RC , (2004) QT PROLONGATION WITH ANTIMICROBIAL AGENTS - UNDERSTANDING THE SIGNIFICANCE.DRUGS. VOL. 64. ISSUE 10. P. 1091-1124 | 52 | 43% | 65 |
9 | CALDERONE, V , TESTAI, L , MARTINOTTI, E , DEL TACCA, M , BRESCHI, MC , (2005) DRUG-INDUCED BLOCK OF CARDIAC HERG POTASSIUM CHANNELS AND DEVELOPMENT OF TORSADE DE POINTES ARRHYTHMIAS: THE CASE OF ANTIPSYCHOTICS.JOURNAL OF PHARMACY AND PHARMACOLOGY. VOL. 57. ISSUE 2. P. 151-161 | 36 | 64% | 12 |
10 | SCHACHTELE, S , TUMENA, T , GASSMANN, KG , FROMM, MF , MAAS, R , (2016) CO-PRESCRIPTION OF QT-INTERVAL PROLONGING DRUGS: AN ANALYSIS IN A LARGE COHORT OF GERIATRIC PATIENTS.PLOS ONE. VOL. 11. ISSUE 5. P. - | 26 | 68% | 0 |
Classes with closest relation at Level 1 |